Peter Hamley joined AstraZeneca (formerly Astra) after completing a BSc at Imperial College, a PhD at Cambridge University and postdoctoral studies at the University of Pennsylvania.  In 2003 he moved to Frankfurt to join Sanofi (formerly Aventis) and lead global chemistry and natural product departments in Germany, France and the US and his groups have contributed to the advancement of many projects into clinical development.  More recently in Business Development he has responsibility for external deal making in drug discovery and has a strong interest in new business models and open innovation in research.  He holds an MBA from Bath University.

Powered by WishList Member - Membership Software